<DOC>
	<DOC>NCT03091894</DOC>
	<brief_summary>studying the effect of adding dexmedetomidine intravenous infusion to propofol intravenous infusion during sedation for drug induced sleep endoscopy</brief_summary>
	<brief_title>Dexmedetomidine Added to Propofol for Drug Induced Sleep Endoscopy</brief_title>
	<detailed_description>In the current study 50 adult patients with obstructive sleep apnea were randomly allocated into one of two groups. Propofol group (25 patients) received only propofol infusion.Propofol-dex. group (25 patients) received dexmedetomidine intravenous infusion in addition to propofol infusion. the success of the sedation during drug induced sleep endoscopy was the primary outcome. The secondary outcomes were the sedation level as evaluated by Modified observer's assessment of alertness sedation(OAA/S) score , the time until sufficient sedation, the total endoscopy time,the incidence of oxygen desaturation and the adverse haemodynamic effects.</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>age more than 18 years patients with obstructive sleep apnea ASA 1and2 patient refusal age less than 18 years morbid obesity known or suspected allergy to the studied drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>dexmedetomidine,propofol,sleep endoscopy,sedation</keyword>
</DOC>